These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35269571)

  • 1. Antisense Therapy Attenuates Phospholamban p.(Arg14del) Cardiomyopathy in Mice and Reverses Protein Aggregation.
    Eijgenraam TR; Stege NM; Oliveira Nunes Teixeira V; de Brouwer R; Schouten EM; Grote Beverborg N; Sun L; Später D; Knöll R; Hansson KM; Amilon C; Janzén D; Yeh ST; Mullick AE; van der Meer P; de Boer RA; Silljé HHW
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DWORF Extends Life Span in a PLN-R14del Cardiomyopathy Mouse Model by Reducing Abnormal Sarcoplasmic Reticulum Clusters.
    Stege NM; Eijgenraam TR; Oliveira Nunes Teixeira V; Feringa AM; Schouten EM; Kuster DWD; van der Velden J; Wolters AHG; Giepmans BNG; Makarewich CA; Bassel-Duby R; Olson EN; de Boer RA; Silljé HHW
    Circ Res; 2023 Dec; 133(12):1006-1021. PubMed ID: 37955153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein Aggregation Is an Early Manifestation of Phospholamban p.(Arg14del)-Related Cardiomyopathy: Development of PLN-R14del-Related Cardiomyopathy.
    Eijgenraam TR; Boogerd CJ; Stege NM; Oliveira Nunes Teixeira V; Dokter MM; Schmidt LE; Yin X; Theofilatos K; Mayr M; van der Meer P; van Rooij E; van der Velden J; Silljé HHW; de Boer RA
    Circ Heart Fail; 2021 Nov; 14(11):e008532. PubMed ID: 34587756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of DWORF does not affect cardiac function in aging and in PLN-R14del cardiomyopathy.
    Stege NM; Oliveira Nunes Teixeira V; Zijlstra SN; Feringa AM; de Boer RA; Silljé HHW
    Am J Physiol Heart Circ Physiol; 2024 Mar; 326(3):H870-H876. PubMed ID: 38334971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy.
    Grote Beverborg N; Später D; Knöll R; Hidalgo A; Yeh ST; Elbeck Z; Silljé HHW; Eijgenraam TR; Siga H; Zurek M; Palmér M; Pehrsson S; Albery T; Bomer N; Hoes MF; Boogerd CJ; Frisk M; van Rooij E; Damle S; Louch WE; Wang QD; Fritsche-Danielson R; Chien KR; Hansson KM; Mullick AE; de Boer RA; van der Meer P
    Nat Commun; 2021 Aug; 12(1):5180. PubMed ID: 34462437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unreponsive to standard heart failure therapy.
    Eijgenraam TR; Boukens BJ; Boogerd CJ; Schouten EM; van de Kolk CWA; Stege NM; Te Rijdt WP; Hoorntje ET; van der Zwaag PA; van Rooij E; van Tintelen JP; van den Berg MP; van der Meer P; van der Velden J; Silljé HHW; de Boer RA
    Sci Rep; 2020 Jun; 10(1):9819. PubMed ID: 32555305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholamban p.Arg14del cardiomyopathy is characterized by phospholamban aggregates, aggresomes, and autophagic degradation.
    Te Rijdt WP; van Tintelen JP; Vink A; van der Wal AC; de Boer RA; van den Berg MP; Suurmeijer AJ
    Histopathology; 2016 Oct; 69(4):542-50. PubMed ID: 26970417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unfolded Protein Response as a Compensatory Mechanism and Potential Therapeutic Target in PLN R14del Cardiomyopathy.
    Feyen DAM; Perea-Gil I; Maas RGC; Harakalova M; Gavidia AA; Arthur Ataam J; Wu TH; Vink A; Pei J; Vadgama N; Suurmeijer AJ; Te Rijdt WP; Vu M; Amatya PL; Prado M; Zhang Y; Dunkenberger L; Sluijter JPG; Sallam K; Asselbergs FW; Mercola M; Karakikes I
    Circulation; 2021 Aug; 144(5):382-392. PubMed ID: 33928785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholamban immunostaining is a highly sensitive and specific method for diagnosing phospholamban p.Arg14del cardiomyopathy.
    Te Rijdt WP; van der Klooster ZJ; Hoorntje ET; Jongbloed JDH; van der Zwaag PA; Asselbergs FW; Dooijes D; de Boer RA; van Tintelen JP; van den Berg MP; Vink A; Suurmeijer AJH
    Cardiovasc Pathol; 2017; 30():23-26. PubMed ID: 28759816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arrhythmia Mechanism and Dynamics in a Humanized Mouse Model of Inherited Cardiomyopathy Caused by Phospholamban R14del Mutation.
    Raad N; Bittihn P; Cacheux M; Jeong D; Ilkan Z; Ceholski D; Kohlbrenner E; Zhang L; Cai CL; Kranias EG; Hajjar RJ; Stillitano F; Akar FG
    Circulation; 2021 Aug; 144(6):441-454. PubMed ID: 34024116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leducq Transatlantic Network of Excellence to Cure Phospholamban-Induced Cardiomyopathy (CURE-PLaN).
    Doevendans PA; Glijnis PC; Kranias EG
    Circ Res; 2019 Sep; 125(7):720-724. PubMed ID: 31513489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholamban Inhibition by a Single Dose of Locked Nucleic Acid Antisense Oligonucleotide Improves Cardiac Contractility in Pressure Overload-Induced Systolic Dysfunction in Mice.
    Morihara H; Yamamoto T; Oiwa H; Tonegawa K; Tsuchiyama D; Kawakatsu I; Obana M; Maeda M; Mohri T; Obika S; Fujio Y; Nakayama H
    J Cardiovasc Pharmacol Ther; 2017 May; 22(3):273-282. PubMed ID: 27811197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myofilament Alterations Associated with Human R14del-Phospholamban Cardiomyopathy.
    Kumar M; Haghighi K; Koch S; Rubinstein J; Stillitano F; Hajjar RJ; Kranias EG; Sadayappan S
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy.
    Haghighi K; Kolokathis F; Gramolini AO; Waggoner JR; Pater L; Lynch RA; Fan GC; Tsiapras D; Parekh RR; Dorn GW; MacLennan DH; Kremastinos DT; Kranias EG
    Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1388-93. PubMed ID: 16432188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes.
    Posch MG; Perrot A; Geier C; Boldt LH; Schmidt G; Lehmkuhl HB; Hetzer R; Dietz R; Gutberlet M; Haverkamp W; Ozcelik C
    Heart Rhythm; 2009 Apr; 6(4):480-6. PubMed ID: 19324307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy.
    Karakikes I; Stillitano F; Nonnenmacher M; Tzimas C; Sanoudou D; Termglinchan V; Kong CW; Rushing S; Hansen J; Ceholski D; Kolokathis F; Kremastinos D; Katoulis A; Ren L; Cohen N; Gho JMIH; Tsiapras D; Vink A; Wu JC; Asselbergs FW; Li RA; Hulot JS; Kranias EG; Hajjar RJ
    Nat Commun; 2015 Apr; 6():6955. PubMed ID: 25923014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early consequences of the phospholamban mutation PLN-R14del
    Maniezzi C; Eskandr M; Florindi C; Ferrandi M; Barassi P; Sacco E; Pasquale V; Maione AS; Pompilio G; Teixeira VON; de Boer RA; Silljé HHW; Lodola F; Zaza A
    Acta Physiol (Oxf); 2024 Mar; 240(3):e14082. PubMed ID: 38214033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study in Polish patients with cardiomyopathy emphasizes pathogenicity of phospholamban (PLN) mutations at amino acid position 9 and low penetrance of heterozygous null PLN mutations.
    Truszkowska GT; Bilińska ZT; Kosińska J; Śleszycka J; Rydzanicz M; Sobieszczańska-Małek M; Franaszczyk M; Bilińska M; Stawiński P; Michalak E; Małek ŁA; Chmielewski P; Foss-Nieradko B; Machnicki MM; Stokłosa T; Ponińska J; Szumowski Ł; Grzybowski J; Piwoński J; Drygas W; Zieliński T; Płoski R
    BMC Med Genet; 2015 Apr; 16():21. PubMed ID: 25928149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A PLN nonsense variant causes severe dilated cardiomyopathy in a novel autosomal recessive inheritance mode.
    Li Z; Chen P; Xu J; Yu B; Li X; Wang DW; Wang DW
    Int J Cardiol; 2019 Mar; 279():122-125. PubMed ID: 30638982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human phospholamban Arg14-deletion mutant localizes to plasma membrane and interacts with the Na/K-ATPase.
    Haghighi K; Pritchard T; Bossuyt J; Waggoner JR; Yuan Q; Fan GC; Osinska H; Anjak A; Rubinstein J; Robbins J; Bers DM; Kranias EG
    J Mol Cell Cardiol; 2012 Mar; 52(3):773-82. PubMed ID: 22155237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.